Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Daiichi Sankyo
Sort By
Newest First
Sign in
1 / 1
1 / 1
Collaboration
AstraZeneca and Daiichi Sankyo Enter Collaboration to Develop and Commercialize New Antibody Drug Conjugate
AstraZeneca
PR-M07-20-NI-41
Jul 27, 2020
Vaccine Manufacturing
Daiichi Sankyo Announces Start of Discussions with AstraZeneca Regarding Supply in Japan of Novel Coronavirus Vaccine
Daiichi-Sankyo
PR-M06-20-NI-036-1473
Jun 26, 2020
FDA Review
Daiichi Sankyo Provides Update on FDA Review of Quizartinib for the Treatment of Patients with Relapsed/Refractory FLT3-ITD AML
Daiichi-Sankyo
PR-M06-19-NI-045
Jun 26, 2019
Oncology
New Analysis Identifies Patient Populations With Cancer-associated VTE Who Could Benefit From Treatment With Oral, Once-daily LIXIANA®▼ (edoxaban)
Daiichi-Sankyo
PR-M09-18-NI-018
Sep 07, 2018
Research
Daiichi Sankyo and DarwinHealth Enter Exclusive Research Collaboration for Novel Cancer Target Initiative
Daiichi-Sankyo
PR-M04-18-NI-028
Apr 09, 2018
